MarketPeel
Insider Trading Intelligence
Pricing
…
PL

Peter F. Lebowitz

BBOT
DIRECTOR · BRIDGEBIO ONCOLOGY THERAPEUTICS, INC. · CIK 0002121402
FILING MIX · LIFETIME100%/0%
BUYS
1
SELLS
0
TOTAL VALUE
$0
COMPANIES
1
ACTIVE SINCE
Mar 2026
HOLDINGS NOW
63,350
AVG SELL PX
—
TRADE KIND
SHOWING 1 / 1
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
No backtest data available for Peter F. Lebowitz. Backtests are computed for purchase (P) and sale (S) transactions with resolvable price history.
Holdings over time
Not enough transaction history to chart holdings.
Trading cadence · quarterly flow
BUY ● SELL ●
2026
FLOW · 1 buys / 0 sellsCOVERAGE · 1 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILED
BBOT
BRIDGEBIO ONCOLOGY THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
63,350——63,350Mar 24, 2026Mar 26, 2026 ↗
Other insiders · BBOT
Loading peer insiders…
About this filer
CIK 0002121402
ROLE
Director
PRIMARY
BBOT
COMPANIES
1
ACTIVE SINCE
Mar 2026
MARKETPEEL · /INSIDER/0002121402DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback